Sigma-receptor imaging by means of I123-IDAB scintigraphy: clinical application in melanoma and non-small cell lung cancer.

Scintigraphy with 1123-N-(2-Diethyl aminoethyl) 4-Iodobenzamide (I123-IDAB), a radiolabeled benzamide, has recently been introduced to visualize sigma receptors in vivo. In this study we evaluated the potential clinical applicability of I123-IDAB scintigraphy in patients with melanoma and in patients with non-small cell lung carcinoma (NSCLC); tumors in… CONTINUE READING